Seroprevalence of Hepatitis B Virus among Adults at High Risk for HIV Transmission Two Decades after Implementation of Nationwide Hepatitis B Virus Vaccination Program in Taiwan

被引:22
作者
Sun, Hsin-Yun [1 ,2 ]
Cheng, Chien-Yu [3 ]
Lee, Nan-Yao [4 ,5 ]
Yang, Chia-Jui [6 ]
Liang, Shiou-Haur [7 ]
Tsai, Mao-Song [6 ]
Ko, Wen-Chien [4 ,5 ]
Liu, Wen-Chun [1 ,2 ]
Wu, Pei-Ying [8 ]
Wu, Cheng-Hsin [1 ,2 ]
Lin, Hsi-Hsun [7 ]
Hung, Chien-Ching [1 ,2 ,9 ,10 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[3] Tao Yuan Gen Hosp, Minist Hlth & Welf, Dept Internal Med, Tao Yuan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan
[5] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[6] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan
[7] I Shou Univ, Dept Med, E Da Hosp, Kaohsiung, Taiwan
[8] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan
[9] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[10] China Med Univ, Taichung, Taiwan
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNIZATION PROGRAM; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; C VIRUS; INFECTION; CHILDREN; RECOMMENDATIONS; ANTIBODY; IMMUNITY;
D O I
10.1371/journal.pone.0090194
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Seroprevalence of hepatitis B virus (HBV) after implementation of universal neonatal HBV vaccination and catch-up vaccination programs remains rarely investigated among the adults who were born in the vaccination era (in or after 1986) and engaged in high-risk sexual behaviors. Materials and Methods: Between 2006 and 2012, we determined HBV surface antigen ([HBsAg), anti-HBs, and HBV core antibody (anti-HBc), hepatitis C virus antibody (anti-HCV) and rapid plasma reagin titers among HIV-infected men who have sex with men (MSM) born during 1984-1985 (Group I: 244 persons) and those born in or after 1986 (Group II: 523), and HIV-uninfected MSM (Group III: 377) and heterosexuals (Group IV: 217) born in or after 1986. Prevalence and incidence of HBV infection were estimated and multivariate analysis was performed to identify factors associated with HBsAg positivity. Results: Compared with Group I, Groups II-IV had a significantly lower prevalence of HBsAg positivity (7.8% vs 3.7%, 2.4%, and 3.2%, respectively); and the prevalence of anti-HBc positivity was also lower for Groups III and IV (30.3% vs. 19.6%, and 18.0%, respectively), but no difference was observed between Groups I and II (30.3% vs. 26.3%). In multivariate analysis, HBsAg positivity was significantly associated with syphilis (adjusted odds ratio, 2.990; 95% confidence interval, 1.502-5.953) and anti-HCV positivity (adjusted odds ratio, 3.402; 95% confidence interval, 1.091-10.614). In subjects of Group II with all-negative HBV markers at baseline, the incidence rate of HBsAg seroconversion was 0.486 episodes per 100 person-years; and for those who received combination antiretroviral therapy containing lamivudine and/or tenofovir, none developed HBsAg seroconversion during the follow-up. Conclusions: Among the adults who were born in or after 1986 and engaged in high-risk sexual behaviors in Taiwan, neonatal HBV vaccination and catch-up vaccination programs conferred long-term protection against HBsAg seroconversion and HBsAg positivity was associated with syphilis and anti-HCV positivity.
引用
收藏
页数:8
相关论文
共 35 条
[11]   Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan [J].
Hsu, HY ;
Chang, MH ;
Ni, YH ;
Chen, HL .
GUT, 2004, 53 (10) :1499-1503
[12]  
Kaplan Jonathan E., 2009, Morbidity and Mortality Weekly Report, V58, P1
[13]   Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus [J].
Laurence, JC .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 :75-83
[14]   Hepatitis B and the Need for a Booster Dose [J].
Leuridan, Elke ;
Van Damme, Pierre .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (01) :68-75
[15]   Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination [J].
Lu, CY ;
Chiang, BL ;
Chi, WK ;
Chang, MH ;
Ni, YH ;
Hsu, HM ;
Twu, SJ ;
Su, IJ ;
Huang, LM ;
Lee, CY .
HEPATOLOGY, 2004, 40 (06) :1415-1420
[16]  
Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1
[17]   Antibody levels and protection after hepatitis B vaccination: Results of a 15-year follow-up [J].
McMahon, BJ ;
Bruden, DL ;
Petersen, KM ;
Bulkow, LR ;
Parkinson, AJ ;
Nainan, O ;
Khristova, M ;
Zanis, C ;
Peters, H ;
Margolis, HS .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) :333-341
[18]   Elimination of Hepatocellular Carcinoma and Acute Hepatitis B in Children 25 Years After a Hepatitis B Newborn and Catch-Up Immunization Program [J].
McMahon, Brian J. ;
Bulkow, Lisa R. ;
Singleton, Rosalyn J. ;
Williams, James ;
Snowball, Mary ;
Homan, Chriss ;
Parkinson, Alan J. .
HEPATOLOGY, 2011, 54 (03) :801-807
[19]   Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies [J].
Ni, Yen-Hsuan ;
Huang, Li-Min ;
Chang, Mei-Hwei ;
Yen, Chung-Jen ;
Lu, Chun-Y ;
You, San-Lin ;
Kao, Jia-Horng ;
Lin, Yu-Chen ;
Chen, Huey-Ling ;
Hsu, Hong-Yuan ;
Chen, Ding-Shinn .
GASTROENTEROLOGY, 2007, 132 (04) :1287-1293
[20]   Minimization of hepatitis B infection by a 25-year universal vaccination program [J].
Ni, Yen-Hsuan ;
Chang, Mei-Hwei ;
Wu, Jia-Feng ;
Hsu, Hong-Yuan ;
Chen, Huey-Ling ;
Chen, Ding-Shinn .
JOURNAL OF HEPATOLOGY, 2012, 57 (04) :730-735